Outcomes of Botulinum Toxin Type A for equinovarus deformity in patients with CVA: A case series.


BACKGROUND There is evidence that Botulinum Toxin-A (BTX-A) reduces focal spasticity associated with equinovarus to improve gait in patients poststroke. However, there is little research examining whether gait improvements are maintained after the effectiveness period of BTX-A injections. The purpose of this observational study was to determine whether… (More)
DOI: 10.1080/09593985.2017.1318420


6 Figures and Tables